Author

R. Dahan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Artzy-Schnirman· 1 shared A. Jones· 1 shared B. D. Piening· 1 shared B. Fox· 1 shared C. Ballesteros-Merino· 1 shared C. Bifulco· 1 shared C. Hansel· 1 shared D. A. Knorr· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. Artzy-Schnirman

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

FcyRIIB is a novel immune checkpoint in the tumor microenvironment limiting activity of Treg-targeting antibodies

D. A. Knorr, R. Leidner, S. Jensen, R. Meng, A. Jones, C. Ballesteros-Merino, R. B. Bell, M. Baez, D. Sprott, C. Bifulco, B. D. Piening, R. Dahan, B. Fox, J. Ravetch

This paper identifies FcyRIIB as an inhibitory Fc receptor limiting Treg depletion by anti-CTLA-4 antibodies and shows Fc engineering can enhance their efficacy.

bioRxiv · Jan 19, 2023 · PreprintImmunology

Artificial Antigen Presenting Cells for Detection and Desensitisation of Auto-reactive T cells Associated with Type 1 Diabetes

A. Artzy-Schnirman, E. Abu-Shah, R. Chandrawati, E. Altman, N. Yusuf, S.-T. Wang, J. Ramos, C. Hansel, M. Haus-cohen, R. Dahan, S. Arif, M. L. Dustin, M. Peakman, Y. Reiter, M. M. Stevens

This paper develops artificial antigen presenting cells (aAPCs) to detect and desensitize autoreactive T cells in type 1 diabetes, showing effectiveness in human and mouse models.

bioRxiv · Dec 26, 2020 · PreprintBioengineering